Form 8-K - Current report:
SEC Accession No. 0001104659-22-086148
Filing Date
2022-08-04
Accepted
2022-08-04 16:18:56
Documents
41
Period of Report
2022-08-04
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2222556d1_8k.htm   iXBRL 8-K 25525
2 EXHIBIT 99.1 tm2222556d1_ex99-1.htm EX-99.1 110102
3 EXHIBIT 99.2 tm2222556d1_ex99-2.htm EX-99.2 37341
7 GRAPHIC tm2222556d1_ex99-1img001.jpg GRAPHIC 4017
8 GRAPHIC tm2222556d1_ex99-2img001.jpg GRAPHIC 151974
9 GRAPHIC tm2222556d1_ex99-2img002.jpg GRAPHIC 452804
10 GRAPHIC tm2222556d1_ex99-2img003.jpg GRAPHIC 135620
11 GRAPHIC tm2222556d1_ex99-2img004.jpg GRAPHIC 333827
12 GRAPHIC tm2222556d1_ex99-2img005.jpg GRAPHIC 149804
13 GRAPHIC tm2222556d1_ex99-2img006.jpg GRAPHIC 192565
14 GRAPHIC tm2222556d1_ex99-2img007.jpg GRAPHIC 155976
15 GRAPHIC tm2222556d1_ex99-2img008.jpg GRAPHIC 114818
16 GRAPHIC tm2222556d1_ex99-2img009.jpg GRAPHIC 195078
17 GRAPHIC tm2222556d1_ex99-2img010.jpg GRAPHIC 122745
18 GRAPHIC tm2222556d1_ex99-2img011.jpg GRAPHIC 151036
19 GRAPHIC tm2222556d1_ex99-2img012.jpg GRAPHIC 204948
20 GRAPHIC tm2222556d1_ex99-2img013.jpg GRAPHIC 290132
21 GRAPHIC tm2222556d1_ex99-2img014.jpg GRAPHIC 304900
22 GRAPHIC tm2222556d1_ex99-2img015.jpg GRAPHIC 134442
23 GRAPHIC tm2222556d1_ex99-2img016.jpg GRAPHIC 497147
24 GRAPHIC tm2222556d1_ex99-2img017.jpg GRAPHIC 195366
25 GRAPHIC tm2222556d1_ex99-2img018.jpg GRAPHIC 332570
26 GRAPHIC tm2222556d1_ex99-2img019.jpg GRAPHIC 334276
27 GRAPHIC tm2222556d1_ex99-2img020.jpg GRAPHIC 160465
28 GRAPHIC tm2222556d1_ex99-2img021.jpg GRAPHIC 274800
29 GRAPHIC tm2222556d1_ex99-2img022.jpg GRAPHIC 128194
30 GRAPHIC tm2222556d1_ex99-2img023.jpg GRAPHIC 134793
31 GRAPHIC tm2222556d1_ex99-2img024.jpg GRAPHIC 409217
32 GRAPHIC tm2222556d1_ex99-2img025.jpg GRAPHIC 197845
33 GRAPHIC tm2222556d1_ex99-2img026.jpg GRAPHIC 197512
  Complete submission text file 0001104659-22-086148.txt   8564354

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20220804.xsd EX-101.SCH 3039
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20220804_lab.xml EX-101.LAB 34476
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20220804_pre.xml EX-101.PRE 22599
35 EXTRACTED XBRL INSTANCE DOCUMENT tm2222556d1_8k_htm.xml XML 3621
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 221136874
SIC: 2834 Pharmaceutical Preparations